Results 111 to 120 of about 4,653 (155)

Disruption of proteoglycan 4 (PRG4)-CD44 signaling modulates chronic synovitis in conditionally inactivated mice. [PDF]

Arthritis Res Ther
Elsaid KA, Zhang L, Zhao T, Marks A, Jenkins D, Jay GD.   +5 more
europepmc   +1 more source

Contribution of Organic Anion Transporter 3 in Delayed Elimination of Methotrexate by Concomitant Administration of Febuxostat. [PDF]

Biopharm Drug Dispos
Ikemura K, Kobayashi S, Wang D, Okuda M.
europepmc   +1 more source

Synthesis of Primary Thioamides by the Insertion of CS₂ into Aldoximes. [PDF]

Org Lett
López-Aguilar M, Ríos-Lombardía N, Barrena-Espés D, Gallegos M, García-Álvarez J, Concellón C, Del Amo V.   +6 more
europepmc   +1 more source

Efficacy and Safety of Dotinurad Versus Febuxostat for the Treatment of Gout: A Randomized, Multicenter, Double-Blind, Phase 3 Trial in China. [PDF]

Arthritis Rheumatol
Sun J, Wang Y, Cheng Y, Guo D, Hu J, Liu D, Gao Z, Li C, Lu Y, Kong X, Liu Y, Jiang Z, Yi B, Zhang H, Xu B, Yu S, Kokan R, Ishikawa K, Kawakatsu M, Zhang Z.   +19 more
europepmc   +1 more source

Preinfusion Glucocorticoid Reduction and Elimination in Patients With Uncontrolled Gout on Pegloticase and Methotrexate: A Case Series. [PDF]

J Clin Rheumatol
Albert J, Vranic Z, LaMoreaux B, LaMoreaux B.   +3 more
europepmc   +1 more source

Research progress on multidimensional intervention strategies for hyperuricemia: Western medicine, Traditional Chinese Medicine, and emerging therapies. [PDF]

Front Endocrinol (Lausanne)
Li X, Chen Z, Zhang Y, Fan C, Chen L, Xu X, Chang J, Qiang W, Jiang H, Liu C.   +9 more
europepmc   +1 more source

Assessing willingness to pay for HLA-B*58:01 genetic testing before allopurinol initiation and its potential impact on future health policy, Thailand. [PDF]

Sci Rep
Towiwat P, Bamrungsawad N, Buttham B, Nakham A, Upakdee N.   +4 more
europepmc   +1 more source

Acute cardiovascular events after discontinuation of xanthine oxidase inhibitors: a cohort study. [PDF]

Clin Rheumatol
Magagnoli J, Cummings TH, Ambati M, Sutton SS, Ambati J.   +4 more
europepmc   +1 more source

Firsekibart for steroid withdrawal in glucocorticoid-dependent refractory gout: a case report. [PDF]

Front Immunol
Tan J, Huang H, Tan L, Li B, She R, Long S.   +5 more
europepmc   +1 more source

Bioequivalence evaluation of generic febuxostat versus Feburic^® in healthy Chinese subjects: a randomized crossover study. [PDF]

BMC Pharmacol Toxicol
Wang F, Ye X, Li F, Kong H, Liao M, Kan M, Zhuang J, Wang A, Meng X.   +8 more
europepmc   +1 more source